Therefore, a few evidences indicate that ARTs antitumor affects may be related with immunoregulatory activities and cancer metabolism changes mainly by decreasing the secretion of immunosuppressive cytokines (TGF-β/IL-10) and the infiltration of inhibitory immune cells such as TRegs and MDScS, while increasing the infiltration of attack cells, T CD8+ and NK with increased antitumor potential [16,21,22,23,24,25]. The gene discussed is TGFB1; the disease is cancer.